By continuing to use the site, you agree to the use of cookies. You can find out more by following this link

Valmet receives repeat order for a new Advantage DCT tissue production line from Papel San Francisco in Mexico

Valmet Oyj's press release on June 8, 2016 at 11:00 a.m. EET

Valmet will supply an Advantage DCT 100TS tissue production machine to Papel San Francisco in Mexico. The new machine will be installed at the company's mill in Mexicali and start-up is planned for the second half of 2017.

The order is included in Valmet's second quarter 2016 orders received. The value of the order is not disclosed

Continuation of good cooperation

The new tissue line will fulfill Papel San Francisco's need of new capacity for standard tissue products. Valmet has previously delivered three tissue machines to the company. Two Advantage DCT machines started up in 2006 and 2009 and one Advantage NTT started up in 2013 which fulfills the company's demand of textured tissue.   

"Our previous installations are running very well. The Advantage DCT machines are operating at high speed and made the world speed record of 2160 m/min already in 2009. The Advantage NTT machine has reached record high production capacity in conventional mode and the textured products are well received on the market. Due to the need to increase our capacity of standard tissue we decided to go for the cost and energy efficient Advantage DCT technology equipped with the Advantage ViscoNip press," says Dario Palma y Meza Espinoza, Operational Director, Papel San Francisco.

"Our relationship with Papel San Francisco is a showcase for how a supplier and customer cooperate to achieve continuous performance improvements with a win-win result. During the years Papel San Francisco has managed to break several records regarding speed and operation performance. Our relationship is built on respect, strong trust and cooperation with professional and technical focus," says Jan Larsson, Sales Director North America, Tissue Mills Business Unit, Valmet.  

Technical information about the delivery

The new tissue machine will have a width of 2.8 m and a design speed of 2,200 m/min and will add 30,000 tons tissue paper per year to Papel San Francisco's current production of toilet tissue, kitchen towels and napkins.

Valmet's scope of delivery will comprise an Advantage DCT 100TS tissue machine. The machine will be equipped with OptiFlo headbox and cast alloy Yankee cylinder. The machine will also be featured with the well proven Advantage tissue technology including ViscoNip press, AirCap hood and WetDust dust system. Start-up and commissioning are also included in the delivery.

Valmet Advantage DCT 100TS tissue machine

About the customer Papel San Francisco

Papel San Francisco started up their first tissue machine in 1980. In the past 35 years the company has grown steadily and are today operating five tissue machines with a yearly capacity of 150 000 tons of tissue products.

VALMET
Corporate Communications

For further information, please contact:

Jan Erikson, VP Sales, Tissue mills, Valmet, tel. +46 705 171490

Jan Larsson, Sales Director North America Tissue mills, Valmet, tel. + 1 404 229 4269

Valmet is the leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries. We aim to become the global champion in serving our customers.

Valmet's strong technology offering includes pulp mills, tissue, board and paper production lines, as well as power plants for bioenergy production. Our advanced services and automation solutions improve the reliability and performance of our customers' processes and enhance the effective utilization of raw materials and energy.

Valmet's net sales in 2015 were approximately EUR 2.9 billion. Our 12,000 professionals around the world work close to our customers and are committed to moving our customers' performance forward - every day. Valmet's head office is in Espoo, Finland and its shares are listed on the Nasdaq Helsinki.

Read more www.valmet.com, www.twitter.com/valmetglobal